Indonesian-Language Application-Based Guided Imagery Therapy for Insomnia and Glycemic Control in Diabetic Patients
NCT ID: NCT07141940
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
66 participants
INTERVENTIONAL
2025-05-06
2025-08-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main questions it aims to answer are:
* Can the app-based guided imagery therapy help improve sleep quality in diabetic patients who have trouble sleeping?
* Can the app-based guided imagery therapy help lowering fasting blood glucose in diabetic patients who have trouble sleeping? Researchers will compare app-based guided imagery therapy to education about how to sleep well, to see if the app works to improve sleep quality and lower blood glucose.
Participants will:
* Receive education about how to sleep well
* Use the app 3 times a week for 4 weeks (only for group who receive the app)
* Visit the clinic after 4 weeks for tests
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Sleep Education Program on Glycemic Control in Hong Kong Chinese Type 2 Diabetic Patients
NCT01881724
Enhancing Diabetes Care by Treating Insomnia
NCT07062406
Effects of Sleep Hygiene Education and Progressive Relaxation Exercise on Anxiety, Sleep Quality and Glycemic Control in Diabetic Patients
NCT06960408
Diabetes Sleep Treatment Trial for Insomnia
NCT03064321
Effects of Optimizing Nocturnal Glycemic Control on Sleep Parameters in Type 1 Diabetes
NCT05560568
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Group
The participants receive psychoeducation at the enrollment. Then, they were asked to use the Indonesian-language application-based auditory guided imagery therapy 3 times a week for 4 weeks.
Indonesian-language application-based auditory guided imagery therapy
This study used a mobile application developed by researchers using Indonesian language to deliver an auditory guided imagery therapy
Control Group
The participants receive only psychoeducation at the enrollment.
Psychoeducation
Psychoeducation consists of sleep hygiene and relaxation therapy (breathing exercise, progressive muscle relaxation, and guided imagery)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indonesian-language application-based auditory guided imagery therapy
This study used a mobile application developed by researchers using Indonesian language to deliver an auditory guided imagery therapy
Psychoeducation
Psychoeducation consists of sleep hygiene and relaxation therapy (breathing exercise, progressive muscle relaxation, and guided imagery)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Already diagnosed with Diabetes Mellitus
* HbA1c less than 12%
* Insomnia Severity Index more than 8
* Lives in Jakarta, Bogor, Depok, Tangerang, or Bekasi
* Able to understand the Indonesian language well
Exclusion Criteria
* No device available to connect with the application
* Inability to independently access or use the application
* Inability to perform self-monitoring of blood glucose at home
* Hearing impairment
* Cognitive impairment or intellectual limitations
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Dr Cipto Mangunkusumo General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rudi Putranto
Dr. dr. Rudi Putranto, Sp.PD, K-P.P.M, MPH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rudi Putranto, Internist, MPH, PhD
Role: PRINCIPAL_INVESTIGATOR
Division of Psychosomatic and Palliative, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cipto Mangunkusumo Hospital
Jakarta Pusat, Jakarta Special Capital Region, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RSCM_IPD_PPM_2025.01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.